Importer of Controlled Substances Application: Akorn, Inc., 32317 [2014-12940]
Download as PDF
<![CDATA[
32317
Federal Register / Vol. 79, No. 107 / Wednesday, June 4, 2014 / Notices
Controlled Substance
Schedule
Fentanyl (9801) ............................
II
The company plans to import the
listed controlled substances in finished
dosage form (FDF) from foreign sources
for analytical testing and clinical trials
in which the foreign FDF will be
compared to the company’s own
domestically-manufactured FDF. This
analysis is required to allow the
company to export domesticallymanufactured FDF to foreign markets.
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
In accordance with 21 CFR
1301.34(a), this is notice that on April
30, 2014, Akorn, Inc., 1222 W. Grand
Avenue, Decatur, Illinois 62522, applied
to be registered as an importer of
Remifentanil (9739), a basic class
controlled substance listed in schedule
II.
The company plans to import
Remifentanil in bulk for use in dosage
form manufacturing.
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–12940 Filed 6–3–14; 8:45 am]
BILLING CODE 4410–09–P
[FR Doc. 2014–12945 Filed 6–3–14; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
Drug Enforcement Administration
DEPARTMENT OF JUSTICE
[Docket No. DEA–392]
Drug Enforcement Administration
Importer of Controlled Substances
Application: Rhodes Technologies
[Docket No. DEA–392]
ACTION:
Importer of Controlled Substances
Application: Akorn, Inc.
ACTION:
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.34(a) on or before July
7, 2014. Such persons may also file a
written request for a hearing on the
application pursuant to 21 CFR 1301.43
on or before July 7, 2014.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been redelegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to sec. 7(g) of 28 CFR part 0,
subpart R, App.
tkelley on DSK3SPTVN1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Mar<15>2010
16:05 Jun 03, 2014
Jkt 232001
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before July 7, 2014. Such persons
may also file a written request for a
hearing on the application pursuant to
21 CFR 1301.43 on or before July 7,
2014.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been redelegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to sec. 7(g) of 28 CFR part 0,
subpart R, App.
In accordance with 21 CFR
1301.34(a), this is notice that on March
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00105
Fmt 4703
Sfmt 4703
Controlled substance
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
Schedule
II
II
The company plans to import the
listed controlled substances in order to
bulk manufacture controlled substances
in Active Pharmaceutical Ingredient
(API) form. The company distributes the
manufactured APIs in bulk to its
customers.
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–12950 Filed 6–3–14; 8:45 am]
BILLING CODE 4410–09–P
Notice of application.
DATES:
Notice of application.
12, 2014, Rhodes Technologies, 498
Washington Street, Coventry, Rhode
Island 02816, applied to be registered as
an importer of the following basic
classes of controlled substances:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Arizona Department of
Corrections
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.34(a) on or before July
7, 2014. Such persons may also file a
written request for a hearing on the
application pursuant to 21 CFR 1301.43
on or before July 7, 2014.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
SUPPLEMENTARY INFORMATION:
E:\FR\FM\04JNN1.SGM
04JNN1
]]>Agencies
[Federal Register Volume 79, Number 107 (Wednesday, June 4, 2014)]
[Notices]
[Page 32317]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-12940]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Akorn, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.34(a) on or before July 7, 2014. Such persons may also file a
written request for a hearing on the application pursuant to 21 CFR
1301.43 on or before July 7, 2014.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, and dispensers of controlled substances
(other than final orders in connection with suspension, denial, or
revocation of registration) has been redelegated to the Deputy
Assistant Administrator of the DEA Office of Diversion Control
(``Deputy Assistant Administrator'') pursuant to sec. 7(g) of 28 CFR
part 0, subpart R, App.
In accordance with 21 CFR 1301.34(a), this is notice that on April
30, 2014, Akorn, Inc., 1222 W. Grand Avenue, Decatur, Illinois 62522,
applied to be registered as an importer of Remifentanil (9739), a basic
class controlled substance listed in schedule II.
The company plans to import Remifentanil in bulk for use in dosage
form manufacturing.
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-12940 Filed 6-3-14; 8:45 am]
BILLING CODE 4410-09-P
